Thank you for participating in BIO-Europe Spring® 2012
2,157 attendees from
1,304 companies participated in
11,172 one-to-one meetings and
135 company presentations on products and technologies.
Save the date and check back in the coming weeks for information on next year's BIO-Europe Spring®, March 11–13, 2013 in Barcelona, Spain.
Use partnering360® to:- Follow up and stay in touch with people you met at BIO-Europe Spring
- Access an archive of all meeting requests your company has sent and received at any partneringONE event
- See which conferences your contacts will attend next
Log in to your BIO-Europe Spring partneringONE® account ►
View impressions of BIO-Europe Spring ►
See videos of BIO-Europe Spring ►
Tell us about your BIO-Europe Spring experience ►
About the BIO-Europe Spring® Conference
BIO-Europe Spring 2012 Highlights
- 11,172 one-to-one meetings - up 21% over 2011
- 2,508 licensing opportunities
posted - up 13% over 2011 - 2,157 delegates - up 20% over 2011
- 1,304 companies - up 15% over 2011
- 135 company presentations
- 67 exhibitors
- 44 countries represented
- 18 workshops and panels
Where the global biotech industry comes to partner
BIO-Europe Spring® is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities.
Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
more ►
Featured speakers
Vaughn KailianManaging Partner
MPM Capital
Roger LongmanCEO
Real Endpoints
Anna ProtopapasExecutive VP
Global Business Development
Takeda Pharmaceuticals
Francesco De RubertisPartner
Index Ventures
Hans SchikanCEO
Prosensa
Moncef SlaouiChairman R&D
GlaxoSmithKline
Paul StoffelsWorldwide Chairman
Pharmaceuticals
Johnson & Johnson
Philip VickersSenior VP R&D
Shire Human Genetic Therapies
Who will you meet?
BIO-Europe Spring annually attracts top international executives from:
- Established and emerging biotech companies
- Pharmaceutical companies
- Institutional financial firms
- Private investors including venture capital and private equity
- Industry related service companies













































